Grant

Grant: ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing (Advanced Research and Invention Agency (ARIA) -> University of Birmingham)

Profile page →

partial50% confidence

2 evidence checks from 1 unique source

Last checked: 4/3/2026

[deterministic-row-match] Partial deterministic match: grantee matched but name did not (48 rows)

Evidence — 1 source, 2 checks

www.aria.org.uk/programme-safeguarded-ai/ARIA(2 checks)

partial50%deterministic-row-match · 4/3/2026

Found: Matched row: {"grantee":"Hashberg Ltd / University of Birmingham","focusArea":"TA1.1","name":"Hyper-optimised Tensor Contraction for Neural Networks Verification","description":"Hashberg Ltd / Univers…

Note: [deterministic-row-match] Partial deterministic match: grantee matched but name did not (48 rows)

partial75%Haiku 4.5 · 3/25/2026

Found: The source confirms the existence of 'ARIA TA3' and references it as a real technical area within the Safeguarded AI programme. However, the source explicitly states that TA3 Phase 2 solicitation will…

Note: The record claims a grant titled 'ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing' dated 2024-09. The source confirms TA3 exists within ARIA's Safeguarded AI programme, but contradicts the premise by stating the programme is NOT proceeding with TA3 Phase 2 and is pivoting focus. The source does not mention 'Biopharmaceutical Manufacturing' specifically as a TA3 focus. The specific identifiers (XqjV4mbMXQ, bEVAImWDe3) and exact date cannot be verified from the source. The record appears to reference a grant that may not have been awarded or may be outdated given the programme's stated pivot away from TA3.

Debug info

Record type: grant

Record ID: 5mv2MnKU_f